Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1999-11-04
2000-11-21
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241841, 4241851, 4241861, 4242041, 4242081, 530324, 530300, A61K 3921, A61K 3900, A61K 3938, A61K 3912, A61K 3800
Patent
active
061499102
ABSTRACT:
This invention relates to peptides and their preparation. The peptides each have a sequence that corresponds to the immunodominant region of the HIV-1 group O gp41 envelope protein. The sequence is characterized in that it does not correspond to any known naturally occurring group O sequence or variant. Furthermore, the peptide binds anti-HIV-1 group O antibodies. There are several uses for the peptides, including the detection of antibodies produced in response to HIV-1 group O infection. The peptides may also be incorporated in mosaics and expressed recombinantly.
De Leys Robert
Zheng Jian
Antar Stacey B.
Nelson Brett
Ortho-Clinical Diagnostics, Inc.
Stucker Jeffrey
LandOfFree
Peptides for the detection of HIV-1 group O does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for the detection of HIV-1 group O, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for the detection of HIV-1 group O will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1254281